About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

NCT07110454·21 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Epiminder, Director of Clinical Trials
CONTACT
800-717-3185 [email protected]

Lead

Epiminder America, Inc.

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Participant completed the DETECT study by receiving an actionable event or by completing the 6-month follow-up visit
Participant continues to have the Minder device implanted

The record

StatusRecruiting

PhaseNo phase

Taking part210

StartedDec 2025

UpdatedOct 22, 2026

Conditions

Epilepsy Epilepsy (Treatment Refractory)

Where21

UAB Epilepsy Center
Birmingham, Alabama, United States
Mayo Clinic - Arizona
Phoenix, Arizona, United States
Stanford
Palo Alto, California, United States